Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
We Are Available 24/ 7. Call Now.
USFDA green-lights first fast-acting insulin biosimilar
The US Food and Drug Administration has approved Merilog as a biosimilar of Novo Nordisk’s product Novolog (insulin aspart) for the improvement of glycaemic control
Walking the IP tightrope between rights, obligations and public health
“Innovation without access does not make sense,” says Dr Carlos Correa, Executive Director of the South Centre and a seasoned voice on intellectual property rights